Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 9Phase 1 3Phase NA 1Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Meningeal Carcinomatosis 2Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Radiosurgery 27Blood Specimen Collection 20Drug Therapy 18Radiotherapy 14Early Intervention, Educational 14Magnetic Resonance Spectroscopy 13Standard of Care 12Pemetrexed 12Carboplatin 12Exercise 11Practice Guidelines as Topic 9X-Rays 8Psychiatric Rehabilitation 8Methods 8Immunotherapy 8Therapeutics 7Surgical Procedures, Operative 7Paclitaxel 7Fluorodeoxyglucose F18 7Surveys and Questionnaires 6Counseling 6Cisplatin 6Biopsy 6Anterior Temporal Lobectomy 6Thoracic Surgery, Video-Assisted 5Liquid Biopsy 5Gemcitabine 5Erlotinib Hydrochloride 5Docetaxel 5Bevacizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Non-Small-Cell Lung × aumolertinib × Clear all
NCT04944069 2021-06-29

ATTRACT

Second Affiliated Hospital of Nanchang University

Phase NA Unknown
69 enrolled
CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡